• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过片段互补重组人拓扑异构酶I

Reconstitution of human topoisomerase I by fragment complementation.

作者信息

Stewart L, Ireton G C, Champoux J J

机构信息

Department of Microbiology, School of Medicine, University of Washington, Seattle 98195-7242, USA.

出版信息

J Mol Biol. 1997 Jun 13;269(3):355-72. doi: 10.1006/jmbi.1997.1056.

DOI:10.1006/jmbi.1997.1056
PMID:9199405
Abstract

Human topoisomerase I (topo I, 91 kDa) is composed of four major domains; the unconserved and highly charged "N-terminal" domain (24 kDa), the conserved "core" domain (54 kDa), a poorly conserved and positively charged "linker" region (5 kDa), and the highly conserved "C-terminal" domain (8 kDa) which contains the active site tyrosine at position 723. Here we demonstrate that human topo I activity can be reconstituted by mixing a 58 kDa recombinant core domain (residues Lys175 to Ala659) with any one of a series of recombinant C-terminal fragments that range in size from 12 kDa (linker and C-terminal domains, residues Leu658 to Phe765) to 6.3 kDa (C-terminal domain residues Gln713 to Phe765). The C-terminal fragments bind tightly to the core domain, forming a 1:1 complex that is stable irrespective of ionic strength (0.01 to 1 M). The reconstituted enzymes are active only over a relatively narrow range of salt concentrations (25 to 200 mM KCl) as compared to the intact topo70 enzyme (missing the N-terminal domain). Under physiological conditions (150 mM KCl and 10 mM Mg2+) they are much more distributive in their mode of action than topo70. The reconstituted enzyme binds DNA with an affinity that is approximately 20-fold lower than that of the intact topo70. In addition, the cleavage/religation equilibrium of the reconstituted enzyme appears to be biased towards religation relative to that of the intact enzyme. Despite differences in the cleavage/religation equilibrium and affinity for DNA, the reconstituted and intact enzymes have identical sequence specificities for the cleavage of duplex DNA or suicide cleavage of oligonucleotide substrates.

摘要

人类拓扑异构酶I(拓扑异构酶I,91 kDa)由四个主要结构域组成;不保守且带高电荷的“N端”结构域(24 kDa)、保守的“核心”结构域(54 kDa)、保守性较差且带正电荷的“连接子”区域(5 kDa)以及高度保守的“C端”结构域(8 kDa),该结构域在723位含有活性位点酪氨酸。在此我们证明,通过将一个58 kDa的重组核心结构域(赖氨酸175至丙氨酸659残基)与一系列重组C端片段中的任何一个混合,即可重建人类拓扑异构酶I的活性,这些重组C端片段的大小从12 kDa(连接子和C端结构域,亮氨酸658至苯丙氨酸765残基)到6.3 kDa(C端结构域谷氨酰胺713至苯丙氨酸765残基)不等。C端片段与核心结构域紧密结合,形成1:1复合物,该复合物在任何离子强度(0.01至1 M)下均稳定。与完整的拓扑异构酶70(缺少N端结构域)相比,重建的酶仅在相对较窄的盐浓度范围(25至200 mM KCl)内具有活性。在生理条件下(150 mM KCl和10 mM Mg2+),它们的作用方式比拓扑异构酶70更为分散。重建的酶与DNA结合的亲和力比完整的拓扑异构酶70低约20倍。此外,重建酶的切割/连接平衡相对于完整酶似乎偏向于连接。尽管在切割/连接平衡和对DNA的亲和力方面存在差异,但重建酶和完整酶在双链DNA切割或寡核苷酸底物自杀切割方面具有相同的序列特异性。

相似文献

1
Reconstitution of human topoisomerase I by fragment complementation.通过片段互补重组人拓扑异构酶I
J Mol Biol. 1997 Jun 13;269(3):355-72. doi: 10.1006/jmbi.1997.1056.
2
Raman and CD spectroscopy of recombinant 68-kDa DNA human topoisomerase I and its complex with suicide DNA-substrate.重组68 kDa人DNA拓扑异构酶I及其与自杀性DNA底物复合物的拉曼光谱和圆二色光谱
Biochemistry. 1998 Oct 13;37(41):14630-42. doi: 10.1021/bi9806495.
3
DNA contacts by protein domains of the molluscum contagiosum virus type-1B topoisomerase.1B型传染性软疣病毒拓扑异构酶的蛋白质结构域与DNA的相互作用。
Virology. 1999 Sep 30;262(2):479-91. doi: 10.1006/viro.1999.9920.
4
Indispensable, functionally complementing N and C-terminal domains constitute site-specific topoisomerase I.不可或缺的、功能互补的N端和C端结构域构成了位点特异性拓扑异构酶I。
J Mol Biol. 2006 Apr 14;357(5):1409-21. doi: 10.1016/j.jmb.2006.01.079. Epub 2006 Feb 7.
5
Biochemical and biophysical analyses of recombinant forms of human topoisomerase I.重组人拓扑异构酶I形式的生化与生物物理分析
J Biol Chem. 1996 Mar 29;271(13):7593-601. doi: 10.1074/jbc.271.13.7593.
6
The domain organization of human topoisomerase I.人类拓扑异构酶I的结构域组织
J Biol Chem. 1996 Mar 29;271(13):7602-8. doi: 10.1074/jbc.271.13.7602.
7
A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay.在DNA松弛试验中,人拓扑异构酶I中的功能性连接子是对喜树碱产生最大敏感性所必需的。
J Biol Chem. 1999 Nov 12;274(46):32950-60. doi: 10.1074/jbc.274.46.32950.
8
Deciphering the distinct role for the metal coordination motif in the catalytic activity of Mycobacterium smegmatis topoisomerase I.解析耻垢分枝杆菌拓扑异构酶I催化活性中金属配位基序的独特作用。
J Mol Biol. 2009 Nov 6;393(4):788-802. doi: 10.1016/j.jmb.2009.08.064. Epub 2009 Sep 3.
9
Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.痘苗病毒DNA拓扑异构酶羧基末端的缺失会影响DNA结合,并增强DNA松弛过程中的分布性。
Biochemistry. 1997 Apr 1;36(13):3909-16. doi: 10.1021/bi962754p.
10
The Zn(II) binding motifs of E. coli DNA topoisomerase I is part of a high-affinity DNA binding domain.大肠杆菌DNA拓扑异构酶I的锌(II)结合基序是高亲和力DNA结合结构域的一部分。
Biochem Biophys Res Commun. 1998 Oct 20;251(2):509-14. doi: 10.1006/bbrc.1998.9500.

引用本文的文献

1
The low endoribonuclease activity and lack of rNMP preference of human mitochondrial topoisomerase 1 protect against ribonucleotide-dependent deletions.人类线粒体拓扑异构酶1的低核糖核酸酶活性和对核糖核苷酸的不偏好性可防止核糖核苷酸依赖性缺失。
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf475.
2
Experimental and computational study on anti-gastric cancer activity and mechanism of evodiamine derivatives.吴茱萸碱衍生物抗胃癌活性及作用机制的实验与计算研究
Front Pharmacol. 2024 May 7;15:1380304. doi: 10.3389/fphar.2024.1380304. eCollection 2024.
3
Topoisomerase IB: a relaxing enzyme for stressed DNA.
拓扑异构酶IB:一种缓解DNA压力的松弛酶。
Cancer Drug Resist. 2020 Mar 19;3(1):18-25. doi: 10.20517/cdr.2019.106. eCollection 2020.
4
Alkoxylalkyl Esters of Nucleotide Analogs Inhibit Polyomavirus DNA Replication and Large T Antigen Activities.核苷酸类似物的烷氧基烷基酯抑制多瘤病毒 DNA 复制和大 T 抗原活性。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01641-20.
5
Swapping of The N-Terminal Domain of Human Topoisomerase 1B with the Corresponding Counterpart Strongly Impairs Enzyme Activity.将人类拓扑异构酶1B的N端结构域与相应的对应结构域进行交换会严重损害酶的活性。
Rep Biochem Mol Biol. 2020 Jan;8(4):366-375.
6
DNA topoisomerase-targeting chemotherapeutics: what's new?靶向DNA拓扑异构酶的化疗药物:有哪些新进展?
Cancer Chemother Pharmacol. 2017 Jul;80(1):1-14. doi: 10.1007/s00280-017-3334-5. Epub 2017 May 20.
7
DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.DNA拓扑异构酶I结构域相互作用影响酶活性及对喜树碱的敏感性。
J Biol Chem. 2015 May 8;290(19):12068-78. doi: 10.1074/jbc.M114.635078. Epub 2015 Mar 20.
8
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.锥虫拓扑异构酶再探讨。新的结构发现及其在药物研发中的作用。
Int J Parasitol Drugs Drug Resist. 2014 Aug 24;4(3):326-37. doi: 10.1016/j.ijpddr.2014.07.006. eCollection 2014 Dec.
9
Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.拓扑异构酶 I 抑制剂诱导的切割位点的序列选择性:分子动力学研究。
Nucleic Acids Res. 2013 Dec;41(22):10010-9. doi: 10.1093/nar/gkt791. Epub 2013 Sep 9.
10
Role of the protein in the DNA sequence specificity of the cleavage site stabilized by the camptothecin topoisomerase IB inhibitor: a metadynamics study.蛋白在喜树碱拓扑异构酶 IB 抑制剂稳定的切割位点的 DNA 序列特异性中的作用:一种元动力学研究。
Nucleic Acids Res. 2013 Dec;41(22):9977-86. doi: 10.1093/nar/gkt790. Epub 2013 Sep 3.